What was the primary driver of revenue growth in the third quarter of 2006?

The primary driver of revenue growth was the acquisition of WellChoice, Inc. in late 2005. This, combined with premium rate increases across all customer types and enrollment in new products like Medicare Part D, significantly boosted revenue.

How has the adoption of FAS 123R affected the company's financial results?

The adoption of FAS 123R (Share-Based Payment) on January 1, 2006, resulted in increased share-based compensation expense. This led to lower net income and earnings per share for the nine months ended September 30, 2006, compared to what they would have been if the company had continued using the previous accounting method. Specifically, it reduced net income by $89.7 million for the nine-month period.

What is the company's position on liquidity and capital resources?

Elevance Health maintained a strong financial condition and liquidity position, with $20.3 billion in cash, cash equivalents, and investments as of September 30, 2006. Operating cash flow increased, and the company has access to a $2.5 billion revolving credit facility and a commercial paper program, providing flexibility for operations, potential acquisitions, and share repurchases.

What legal proceedings are notable for the company?

The company entered into a significant settlement agreement in July 2005 to resolve multi-district litigation (CMA Litigation, Shane Litigation, Thomas Litigation) with physicians nationwide, agreeing to cash payments totaling up to $198 million. Final payments were made in October 2006. The WellChoice entity, now a subsidiary, remains a defendant in the Thomas Litigation, which the company intends to defend vigorously.

ELV 10-Q Quarterly Report Q3 FY2006 — Revenue, Net Income, EPS

Summary

Elevance Health (formerly WellPoint, Inc.) reported strong third-quarter 2006 results, demonstrating significant growth driven by the acquisition of WellChoice, Inc. and organic premium increases across its various customer segments. Total revenues saw a substantial year-over-year increase, reflecting higher premium and administrative fee income. Net income also grew considerably, leading to improved earnings per share. The company's operational efficiency improved, with a decrease in the selling, general, and administrative expense ratio, despite increased share-based compensation expenses following the adoption of new accounting standards. The Health Care segment remains the largest contributor to revenue and operating gain, with continued expansion in National Accounts and BlueCard membership. The company also highlighted its strategic entry into the Medicare Part D market, which is contributing to membership growth and prescription volume. Elevance Health continues to actively manage its capital structure, with significant share repurchases undertaken during the period. The company maintains a strong liquidity position, supported by operating cash flows and available credit facilities, enabling it to meet its financial obligations and pursue strategic growth initiatives.

Key Highlights

1Total revenues increased by 29% to $14.2 billion for the three months ended September 30, 2006, compared to the same period in 2005, largely driven by the WellChoice acquisition and premium rate increases.
2Net income rose by 27% to $810.8 million for the third quarter of 2006, with diluted EPS increasing to $1.29 from $1.02 in the prior year.
3Medical membership grew to 34.2 million, a 2% increase on a comparable basis, primarily due to growth in National Accounts and BlueCard businesses.
4The company launched Medicare Part D Prescription Drug Plans effective January 1, 2006, and reported 1.6 million Medicare Part D members as of September 30, 2006.
5Selling, general, and administrative (SG&A) expenses increased but the SG&A expense ratio decreased by 130 basis points to 15.5% on a comparable basis, indicating improved operational leverage.
6The company repurchased approximately 5.4 million shares for $399.6 million during the third quarter of 2006 as part of its ongoing share repurchase program.
7Long-term debt increased due to financing for the WellChoice acquisition, but the debt-to-total capital ratio remained manageable at 23.3% as of September 30, 2006.

Elevance Health, Inc. Quarterly Report for Q3 Ended Sep 30, 2006

Summary

Key Highlights

Frequently Asked Questions